J.P. Morgan discloses share dealings in Kangji Medical Holdings

J.P. Morgan Securities PLC, an associate connected with the offeror and ultimately owned by JPMorgan Chase & Co., disclosed dealings in Kangji Medical Holdings Limited shares on October 23, 2025. These transactions were made for its own account to hedge Delta 1 products from unsolicited client-driven orders.

The disclosed activities include several sale transactions and one purchase. J.P. Morgan sold a total of 39,993 shares across three separate deals, receiving a combined $359,109.75. The highest price received for these sales was $9.0200 per share, with the lowest being $8.9600.

Conversely, J.P. Morgan purchased 38,500 shares at $8.9900 per share, totaling $346,477.17. The disclosure provides transparency on J.P. Morgan’s involvement in Kangji Medical Holdings during its ongoing privatization.